3,3',3''-(1,3,5-Triazinane-1,3,5-triyl)tris(N,N-dimethylpropan-1-amine), 95.0%, 5g

2,7-Naphthyridin-1-amine, 95.0%, 1g

(R)-1-(tert-Butoxycarbonyl)-2-(4-fluorobenzyl)pyrrolidine-2-carboxylic acid, 95.0%, 250mg

4-Chloro-2-(4-(ethoxycarbonyl)-1,5-dimethyl-1H-pyrrol-2-yl)benzoic acid, 97%, 250mg

(R)-2-(1,3-bis(benzyloxy)-1,3-dioxopropan-2-yl)-4-methylpentanoic acid, 98%, 1g

Hydroxy{[(4-methylphenyl)sulfonyl]oxy}phenyliodine (HTIB), 98.00%, 500g

2,3-Dihydropyrazolo[5,1-b]oxazole-7-carboxylic acid, 250mg

Allyl p-Tolyl Ether>95.0%(GC)25g

[1,1'-Bi(cyclopropane)]-2-carboxylic acid, 90%, 50mg

Dimethyl (2-Oxo-3-phenoxypropyl)phosphonate>98.0%(GC)200mg

4-Methylmorpholine N-Oxide>97.0%(T)5g

TERT-BUTYL 2-(6-BROMO-1H-INDOL-3-YL)ETHYLCARBAMATE, 95.0%, 250mg

4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide, 98.0%, 100g